Noxopharm Corporate Presentation (January), page-6

But for newbies they need to consider so much. Only to quote your recent thoughts.

""...ImoSo many new IPO’s in oncology in recent times and many raising huge capital and mostly in preclinical studies onlyResearch new and recent nasdaq listingsMany raising tens of millions of dollars and have or will have huge market capsThe Cambridge, MA-based company plans to raise $151 million by offering 8.9 million shares at a price range of $16 to $18. At the midpoint of the proposed range, Black Diamond Therapeutics would command a fully diluted market value of $572 million."...

what are the chances before diving in.
DYOR
IMO.